Item(by='JumpCrisscross', descendants=None, kids=[25934221], score=None, time=1611781778, title=None, item_type='comment', url=None, parent=25933934, text='&gt; <i>a non-charitable approach would be to undercut by only 30-50% instead of 90%</i><p>Not if you&#x27;re fighting deeply entrenched incumbents. Switching costs are huge, financially and politically. You need patients to hammer their providers to give them access to these drugs through this channel.<p>50% off is big, but it&#x27;s something incumbents could match. 90% off leaves you with a profit margin, gets you PR points and holds the hounds at bay. Bonus: if you work out your competitors&#x27; debt loads and price at a level that they couldn&#x27;t, financially, sustain.')